(R)-trans-Atracurium Besylate-d4
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
(R)-trans-Atracurium Besylate-d4 Product Information
(R)-trans-Atracurium Besylate-d4 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-98748.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
(R)-trans-Atracurium Besylate-d4
CAT No.
CS-T-98748
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C65H78D4N2O18S2
Molecular Weight
1247.5
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
(R)-trans-Atracurium Besylate-d4 is supplied with detailed characterization data compliant with regulatory guideline. (R)-trans-Atracurium Besylate-d4 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
((R)trans-Atracurium Besylate-d4 is a labelled form of (R)-trans-Atracurium Besylate that has neuromuscular blocking effects and does not produce cardiovascular effects or increase plasma histamine concentrations.
Synonyms
(R)-trans-Atracurium Besylate-d4
Application Notes
((R)trans-Atracurium Besylate-d4 is a labelled form of (R)-trans-Atracurium Besylate that has neuromuscular blocking effects and does not produce cardiovascular effects or increase plasma histamine concentrations.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.